Rang	Name	Position
1	Dr. Eric E. Poma Ph.D.	Interim CFO, Treasurer, Principal Acc. Officer, CEO, Chief Scientific Officer & Director
2	Ms. Kristen Quigley B.A.	Chief Operating Officer
3	Dr. Grace Kim Ph.D.	Chief Strategy Officer & Head of IR
4	Dr. Michelle Iwamoto-Fan J.D., Ph.D.	Senior Vice President & General Counsel
5	Dr. Joseph Phillips Ph.D.	Senior VP & Head of CMC Development
6	Dr. Chris Moore Ph.D.	Senior VP and Head of Preclinical Development & Translational Medicine

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Bellevue Group AG	19,44%	0,00 Mio. USD
2	SILVERARC CAPITAL MANAGEMENT, LLC	9,48%	0,00 Mio. USD
3	Bvf Inc	7,93%	0,00 Mio. USD
4	Bank of Montreal	1,11%	0,00 Mio. USD
5	BMO Capital Markets Corp.	1,11%	0,00 Mio. USD
6	Vanguard Group Inc	0,77%	0,00 Mio. USD
7	Geode Capital Management, LLC	0,72%	0,00 Mio. USD
8	BlackRock Inc	0,58%	0,00 Mio. USD
9	Invst LLC	0,36%	0,00 Mio. USD
10	Renaissance Technologies Corp	0,21%	0,00 Mio. USD
11	State Street Corp	0,21%	0,00 Mio. USD
12	The Carlyle Group Inc	0,20%	0,00 Mio. USD
13	Morgan Stanley - Brokerage Accounts	0,08%	0,00 Mio. USD
14	PFS Partners, LLC	0,05%	0,00 Mio. USD
15	Tower Research Capital LLC	0,05%	0,00 Mio. USD
16	Barclays PLC	0,01%	0,00 Mio. USD
17	Advisor Group Holdings, Inc.	0,01%	0,00 Mio. USD
18	Bank of America Corp	0,00%	0,00 Mio. USD
19	TSFG, LLC	0,00%	0,00 Mio. USD
20	JPMorgan Chase & Co	0,00%	0,00 Mio. USD